191 related articles for article (PubMed ID: 25315097)
1. Avoiding detrimental human immune response against Mammalian extracellular matrix implants.
Galili U
Tissue Eng Part B Rev; 2015 Apr; 21(2):231-41. PubMed ID: 25315097
[TBL] [Abstract][Full Text] [Related]
2. Acceleration of wound healing by α-gal nanoparticles interacting with the natural anti-Gal antibody.
Galili U
J Immunol Res; 2015; 2015():589648. PubMed ID: 25922849
[TBL] [Abstract][Full Text] [Related]
3. Induced Remodeling of Porcine Tendons to Human Anterior Cruciate Ligaments by α-GAL Epitope Removal and Partial Cross-Linking.
Stone KR; Walgenbach A; Galili U
Tissue Eng Part B Rev; 2017 Aug; 23(4):412-419. PubMed ID: 28068870
[TBL] [Abstract][Full Text] [Related]
4. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
Galili U
Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
[TBL] [Abstract][Full Text] [Related]
5. Accelerated healing of skin burns by anti-Gal/alpha-gal liposomes interaction.
Galili U; Wigglesworth K; Abdel-Motal UM
Burns; 2010 Mar; 36(2):239-51. PubMed ID: 19501971
[TBL] [Abstract][Full Text] [Related]
6. α1,3Galactosyltransferase knockout pigs produce the natural anti-Gal antibody and simulate the evolutionary appearance of this antibody in primates.
Galili U
Xenotransplantation; 2013; 20(5):267-76. PubMed ID: 23968556
[TBL] [Abstract][Full Text] [Related]
7. α-Gal Nanoparticles Mediated Homing of Endogenous Stem Cells for Repair and Regeneration of External and Internal Injuries by Localized Complement Activation and Macrophage Recruitment.
Galili U; Goldufsky JW; Schaer GL
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232789
[TBL] [Abstract][Full Text] [Related]
8. The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy.
Galili U
Immunol Cell Biol; 2005 Dec; 83(6):674-86. PubMed ID: 16266320
[TBL] [Abstract][Full Text] [Related]
9. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
LaTemple DC; Abrams JT; Zhang SY; Galili U
Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
[TBL] [Abstract][Full Text] [Related]
10. Biosynthesis of α-Gal Epitopes (Galα1-3Galβ1-4GlcNAc-R) and Their Unique Potential in Future α-Gal Therapies.
Galili U
Front Mol Biosci; 2021; 8():746883. PubMed ID: 34805272
[TBL] [Abstract][Full Text] [Related]
11. Cancer immunotherapy for pancreatic cancer utilizing α-gal epitope/natural anti-Gal antibody reaction.
Tanemura M; Miyoshi E; Nagano H; Eguchi H; Matsunami K; Taniyama K; Hatanaka N; Akamatsu H; Mori M; Doki Y
World J Gastroenterol; 2015 Oct; 21(40):11396-410. PubMed ID: 26523105
[TBL] [Abstract][Full Text] [Related]
12. Anti-Gal: an abundant human natural antibody of multiple pathogeneses and clinical benefits.
Galili U
Immunology; 2013 Sep; 140(1):1-11. PubMed ID: 23578170
[TBL] [Abstract][Full Text] [Related]
13. α-Gal Nanoparticles in Wound and Burn Healing Acceleration.
Galili U
Adv Wound Care (New Rochelle); 2017 Mar; 6(3):81-92. PubMed ID: 28289553
[No Abstract] [Full Text] [Related]
14. Rapid recruitment and activation of macrophages by anti-Gal/α-Gal liposome interaction accelerates wound healing.
Wigglesworth KM; Racki WJ; Mishra R; Szomolanyi-Tsuda E; Greiner DL; Galili U
J Immunol; 2011 Apr; 186(7):4422-32. PubMed ID: 21357545
[TBL] [Abstract][Full Text] [Related]
15. Accelerated Burn Healing in a Mouse Experimental Model Using α-Gal Nanoparticles.
Galili U
Bioengineering (Basel); 2023 Oct; 10(10):. PubMed ID: 37892895
[TBL] [Abstract][Full Text] [Related]
16. Increasing Efficacy of Enveloped Whole-Virus Vaccines by In situ Immune-Complexing with the Natural Anti-Gal Antibody.
Galili U
Med Res Arch; 2021 Jul; 9(7):. PubMed ID: 34853815
[TBL] [Abstract][Full Text] [Related]
17. Antibody-mediated accommodation of heart grafts expressing an incompatible carbohydrate antigen.
Mohiuddin MM; Ogawa H; Yin DP; Shen J; Galili U
Transplantation; 2003 Feb; 75(3):258-62. PubMed ID: 12589143
[TBL] [Abstract][Full Text] [Related]
18. Differential immune responses to alpha-gal epitopes on xenografts and allografts: implications for accommodation in xenotransplantation.
Tanemura M; Yin D; Chong AS; Galili U
J Clin Invest; 2000 Feb; 105(3):301-10. PubMed ID: 10675356
[TBL] [Abstract][Full Text] [Related]
19. In vivo targeting of vaccinating tumor cells to antigen-presenting cells by a gene therapy method with adenovirus containing the alpha1,3galactosyltransferase gene.
Deriy L; Ogawa H; Gao GP; Galili U
Cancer Gene Ther; 2005 Jun; 12(6):528-39. PubMed ID: 15818383
[TBL] [Abstract][Full Text] [Related]
20. Xenogeneic thyroid-stimulating hormone-like activity of the human natural anti-Gal antibody. Interaction of anti-Gal with porcine thyrocytes and with recombinant human thyroid-stimulating hormone receptors expressed on mouse cells.
Winand RJ; Anaraki F; Etienne-Decerf J; Galili U
J Immunol; 1993 Oct; 151(7):3923-34. PubMed ID: 8104224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]